TGX-221

CAS No. 663619-89-4

TGX-221 ( TGX221;TGX 221 )

Catalog No. M15529 CAS No. 663619-89-4

A potent, selective PI3K p110β inhibitor with IC50 of 8.5 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 41 In Stock
5MG 61 In Stock
10MG 106 In Stock
25MG 206 In Stock
50MG 340 In Stock
100MG 530 In Stock
500MG 1134 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    TGX-221
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, selective PI3K p110β inhibitor with IC50 of 8.5 nM.
  • Description
    A potent, selective PI3K p110β inhibitor with IC50 of 8.5 nM; weakly inhibits p110δ (IC50=211 nM), and no activity against p110α (IC50>1 uM); inhibits platelet-ECC interaction, platelet aggregation and platelet-granulocyte binding; shows anti-thrombotic effectt devoid of other cardiovascular actions in rats.
  • Synonyms
    TGX221;TGX 221
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    PI3K
  • Recptor
    p110α;p110β;p110γ;p110δ
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    663619-89-4
  • Formula Weight
    364.44
  • Molecular Formula
    C21H24N4O2
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    O=C1C=C(N2CCOCC2)N=C3N1C=C(C)C=C3C(NC4=CC=CC=C4)C
  • Chemical Name
    4H-Pyrido[1,2-a]pyrimidin-4-one, 7-methyl-2-(4-morpholinyl)-9-[1-(phenylamino)ethyl]-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Frazzetto M, et al. Biochem J. 2008 Sep 15;414(3):383-90.
2. Sturgeon SA, et al. Eur J Pharmacol. 2008 Jun 10;587(1-3):209-15.
3. Chaussade C, et al. Biochem J. 2007 Jun 15;404(3):449-58.
4. Straub A, et al. Thromb Haemost. 2008 Mar;99(3):609-15.
molnova catalog
related products
  • 740 Y-P(TFA)

    740 Y-P(TFA) is a potent and cell-permeable activator of PI3K.740 Y-P is a synthetic biotinylated peptide.

  • CZC24832

    CZC24832 is a selective inhibitor of PI 3-kinase γ (IC50 = 1.0 μM in a PI 3-Kγ-dependent fMLP-induced neutrophil migration assay).

  • TGR-1202 R-enantiome...

    TGR-1202 R-enantiomer is is the less active enantiomer of TGR-1202 (Umbralisib), TGR-1202 is a potent, selective, orally available PI3Kδ inhibitor with IC50 of 22 nM.